Chronic Hemodialysis Patients Clinical Trial
— Needles
The aim of this observational study in patients chronically hemodialyzed by a native
arterio-venous fistula is to determine the impact of the use of semi-blunt needles on the
quality of the punction. The investigators have observed that cannulation with blunt needles
(button-hole method) is sometimes difficult and the use of a sharp needle may be necessary,
with consequently more hematomes and infections. Our hypothesis is that canulation with
semi-blunt needles would be easier than with classical blunt needles, and consequently the
use of sharp needles would become less frequent.
Inclusion criteria and study design are detailed below.
Status | Completed |
Enrollment | 50 |
Est. completion date | March 2009 |
Est. primary completion date | March 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Chronic hemodialysis patients - Aged 18 years or more - Dialyzed by a native arterio-venous fistula - Cannuled by buttonhole method with blunt needles Exclusion Criteria: - Acute hemodialysis - Puncture with 14G needles - Puncture with a sole needle - Arterio-venous grafts - Patients transferred from another centre |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Belgium | Cliniques Universitaires Saint Luc | Brussels |
Lead Sponsor | Collaborator |
---|---|
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of AVF hematomes | Two months | No | |
Primary | Incidence of use of sharp needles | Two months | No | |
Secondary | Incidence of trampoline-effect | Two months | No | |
Secondary | Incidence of AVF infections | Two months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04420338 -
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
|
N/A | |
Not yet recruiting |
NCT05410275 -
Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
|
Phase 3 |